HuR regulates phospholamban expression in isoproterenol-induced cardiac remodeling.
The elevated expression of phospholamban (PLB) has been observed in heart failure and cardiac remodeling, inhibiting the affinity of Ca2+ pump to Ca2+ thereby impairing heart relaxation. However, the mechanisms underlying the regulation of PLB remains to be further studied. The present study aims to test the role of RNA binding protein HuR in the regulation of PLB and the impact of this regulatory process in cardiac remodeling. A mouse model specifically deleted HuR in cardiomyocytes were used for testing the role of HuR in regulating PLB during isoproterenol (ISO)-induced cardiac remodeling. HuR deficiency did not significantly influence the phenotype and function of mouse heart under static status. However, deletion of HuR in cardiomyocytes mitigated the effect of ISO in inducing PLB expression and reducing β1-AR expression, in turn aggravating ISO-induced myocardial hypertrophy and cardiac fibrosis. In H9C2 cells, association of HuR with PLB and β1-AR mRNAs stabilized PLB mRNA and destabilized β1-AR mRNA, respectively. HuR stabilizes PLB mRNA and destabilizes β1-AR mRNA. The HuR-PLB and HuR-β1-AR regulatory processes impact on ISO-induced cardiac remodeling. PLB, the reversible inhibitor of SERCA2A, is of critical importance for the SR Ca2+ sequestration thereby the excitation-contraction coupling of myocytes and myocardial remodeling. The activity of PLB could be inhibited by β1-AR-cAMP-PKA pathway through PKA-mediated protein phosphorylation. The present study demonstrated that HuR is able to modulate cardiac remodeling by regulating the expression of PLB and β1-AR. These findings reveal novel mechanisms controlling myocardial remodeling and may provide new clues for strategies to interfere cardiac remodeling-related heart disorders in humans.